Search research articles
Contact Us
Filters
Showing results (121-130 of 140) with videos related to
Page
of 14
Sort By:
International Journal of Biological Sciences
|
September 17, 2025
Senescent Tumoral HLA-E Reshapes Microenvironment through Impairing NK Cell-Dendritic Cell-T Cell Network in Malignant Pleural Effusion from Lung Cancer
Ying-Ming Tsai, Jen-Yu Hung, Yu-Yuan Wu, et al.
Cancers
|
April 30, 2021
Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer
Cheng-Hao Chuang, Hsiao-Ling Chen, Hsiu-Mei Chang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
February 26, 2020
Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan
Yuh-Min Chen, James Chih-Hsin Yang, Wu-Chou Su, et al.
Cancers
|
April 13, 2023
Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with <i>EGFR</i>-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib
Ming-Ju Tsai, Jen-Yu Hung, Juei-Yang Ma, et al.
Hepatology International
|
December 1, 2021
Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study)
Jee-Fu Huang, Ming-Yen Hsieh, Yu-Ju Wei, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 15, 2021
Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non-small-cell lung cancer: a multicenter study using targeted next-generation sequencing
Yen-Ting Lin, Chi-Lu Chiang, Jen-Yu Hung, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 11, 2026
Amivantamab plus chemotherapy versus chemotherapy for first-line treatment of participants with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer: PAPILLON Asia subgroup analysis
Caicun Zhou, Ke-Jing Tang, Baogang Liu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2021
Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study
Melissa L Johnson, Zanete Zvirbule, Konstantin Laktionov, et al.
Cell
|
August 19, 2007
IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway
Dung-Fang Lee, Hsu-Ping Kuo, Chun-Te Chen, et al.
The New England Journal of Medicine
|
October 23, 2023
Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions
Caicun Zhou, Ke-Jing Tang, Byoung Chul Cho, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 140) with videos related to
Sort By:
Page
of 14
International Journal of Biological Sciences
|
September 17, 2025
Senescent Tumoral HLA-E Reshapes Microenvironment through Impairing NK Cell-Dendritic Cell-T Cell Network in Malignant Pleural Effusion from Lung Cancer
Ying-Ming Tsai, Jen-Yu Hung, Yu-Yuan Wu, et al.
Cancers
|
April 30, 2021
Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer
Cheng-Hao Chuang, Hsiao-Ling Chen, Hsiu-Mei Chang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
February 26, 2020
Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan
Yuh-Min Chen, James Chih-Hsin Yang, Wu-Chou Su, et al.
Cancers
|
April 13, 2023
Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with <i>EGFR</i>-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib
Ming-Ju Tsai, Jen-Yu Hung, Juei-Yang Ma, et al.
Hepatology International
|
December 1, 2021
Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study)
Jee-Fu Huang, Ming-Yen Hsieh, Yu-Ju Wei, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 15, 2021
Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non-small-cell lung cancer: a multicenter study using targeted next-generation sequencing
Yen-Ting Lin, Chi-Lu Chiang, Jen-Yu Hung, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 11, 2026
Amivantamab plus chemotherapy versus chemotherapy for first-line treatment of participants with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer: PAPILLON Asia subgroup analysis
Caicun Zhou, Ke-Jing Tang, Baogang Liu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2021
Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study
Melissa L Johnson, Zanete Zvirbule, Konstantin Laktionov, et al.
Cell
|
August 19, 2007
IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway
Dung-Fang Lee, Hsu-Ping Kuo, Chun-Te Chen, et al.
The New England Journal of Medicine
|
October 23, 2023
Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions
Caicun Zhou, Ke-Jing Tang, Byoung Chul Cho, et al.
Page
of 14